NewLimit · 18 hours ago
Senior/Research Associate
South San Francisco
Full-time
Onsite
Mid, Senior Level
$75K/yr - $100K/yr
2+ years expNewLimit is a biotechnology company working to radically extend human healthspan. They are seeking a Senior/Research Associate to support the development of in vitro assays and pre-clinical models for age-related diseases, focusing on restoring youthful function in aged endothelial cells.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Isolate cells from primary tissues to optimize in vitro functional assays
Develop pre‑clinical models of age-related dysfunction
Collaborate with our Single Cell Technology, Epigenetic Editing, and Predictive Modeling teams to design, build, and test epigenetic reprogramming interventions at scale
Support the development of in vivo nucleic acid delivery methods for endothelial cells
Analyze and interpret experimental data to drive pre-clinical decision making
Qualification
Required
Bachelor's degree in cell biology, molecular biology, biochemistry or a related field with 2‑5 years of relevant industry or academic experience
Proficiency in primary mammalian cell culture and animal handling techniques for rodent models
Proficiency in flow cytometry techniques
Exceptional organizational skills, as demonstrated by detailed record-keeping in a lab notebook and an ability to effectively carry out multiple ongoing projects or experiments
Preferred
Experience with isolation and functional characterization of primary cells
Experience developing animal models of cell dysfunction and/or injury
Experience with FACS and flow cytometry
Experience using computational tools to automate routine data analysis (e.g. Python, R, etc.)
Benefits
Health, dental, and vision insurance
401(k) with company match
Paid parental leave
Industry-leading paid time off (PTO) — 20 days/year for all employees + holidays
Meals and snacks on-site
Company
NewLimit
NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
11-50 employees
H1B Sponsorship
NewLimit has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (2)
Funding
Current Stage
Growth StageTotal Funding
$247.25MKey Investors
Kleiner Perkins
2025-10-20Convertible Note· $45M
2025-05-06Series B· $130M
2023-05-16Series A· $72.25M
Leadership Team
Blake Byers
Co-Founder
Recent News
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-11-28
2025-11-17
Company data provided by crunchbase